The Parthenon LLC Decreases Stake in Teleflex Incorporated (NYSE:TFX)

The Parthenon LLC Decreases Stake in Teleflex Incorporated (NYSE:TFX)

Other hedge funds have also bought and sold shares of the company. Pennsylvania Trust Co boosted its position in Teleflex by 0.7% in the first quarter. Pennsylvania Trust Co now owns 2,165 shares of the medical technology company’s stock valued at $419,000 after buying an additional 15 shares in the last quarter. Mn Services Vermogensbeheer B.V. boosted its position in Teleflex by 3.1% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 1,175 shares of the medical technology company’s stock valued at $213,000 after buying an additional 35 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its position in Teleflex by 0.6% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 6,553 shares of the medical technology company’s stock valued at $1,270,000 after buying an additional 37 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Teleflex by 0.6% in the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,560 shares of the medical technology company’s stock valued at $1,271,000 after buying an additional 38 shares in the last quarter. Finally, Creative Planning boosted its position in Teleflex by 3.7% in the first quarter. Creative Planning now owns 2,259 shares of the medical technology company’s stock valued at $438,000 after buying an additional 81 shares in the last quarter. Institutional investors own 92.95% of the company’s stock.

Parthenon LLC cut its position in shares of Teleflex Incorporated (NYSE:TFX) by 0.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,650 shares of the medical technology company’s stock after selling 50 shares during the period. Parthenon LLC’s holdings in Teleflex were worth $2,628,000 as of its most recent SEC filing.

Shares of Teleflex Incorporated (NYSE TFX) traded down 0.63% during midday trading on Wednesday, hitting $203.13. 187,768 shares of the stock were exchanged. Teleflex Incorporated has a 1-year low of $136.53 and a 1-year high of $216.37. The firm has a market capitalization of $9.14 billion, a price-to-earnings ratio of 42.16 and a beta of 1.06. The stock’s 50-day moving average price is $207.61 and its 200-day moving average price is $195.00.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, May 4th. The medical technology company reported $1.80 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.11. Teleflex had a return on equity of 16.17% and a net margin of 11.75%. The company had revenue of $487.90 million during the quarter, compared to analyst estimates of $472.81 million. During the same period in the prior year, the company earned $1.52 earnings per share. The firm’s revenue was up 14.8% on a year-over-year basis. On average, analysts forecast that Teleflex Incorporated will post $8.16 EPS for the current year.

Several equities analysts recently weighed in on the stock. BidaskClub cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Monday. Zacks Investment Research cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Thursday, June 22nd. Leerink Swann lifted their price objective on shares of Teleflex from $215.00 to $220.00 and gave the stock a “market perform” rating in a research report on Friday, June 9th. Needham & Company LLC reaffirmed a “buy” rating and set a $224.00 price objective on shares of Teleflex in a research report on Friday, May 5th. Finally, Deutsche Bank AG lifted their price objective on shares of Teleflex from $213.00 to $220.00 and gave the stock a “buy” rating in a research report on Monday, May 8th. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $217.00.

In other Teleflex news, VP John Deren sold 2,246 shares of the company’s stock in a transaction that occurred on Tuesday, May 9th. The stock was sold at an average price of $194.07, for a total transaction of $435,881.22. Following the sale, the vice president now directly owns 3,989 shares in the company, valued at $774,145.23. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Stephen K. M.D. Klasko sold 200 shares of the company’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $208.10, for a total value of $41,620.00. Following the sale, the director now owns 8,080 shares in the company, valued at $1,681,448. The disclosure for this sale can be found here. Over the last three months, insiders have sold 10,346 shares of company stock valued at $2,038,174. 2.39% of the stock is owned by corporate insiders.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Related posts

Leave a Comment